Comment on

• Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

  McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez-Torres M, Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore D, Blackman N, Jenkins J, Afdhal NH; TPL102357 Study Group. McHutchison JG, et al. N Engl J Med. 2007 Nov 29;357(22):2227-36. doi: 10.1056/NEJMoa073255. N Engl J Med. 2007. PMID: 18046027 Clinical Trial.
• Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.

  Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, Arning M, Provan D, Jenkins JM. Bussel JB, et al. N Engl J Med. 2007 Nov 29;357(22):2237-47. doi: 10.1056/NEJMoa073275. N Engl J Med. 2007. PMID: 18046028 Clinical Trial.